Objectives: To provide an account of implementation of the Epic Beaker 2014 clinical pathology module at Stanford University Medical Center and highlight strengths and weaknesses of the system.
Methods: Based on a formal selection process, Stanford selected Epic Beaker to replace Sunquest as the clinical laboratory information system (LIS). The rationale included integration between the LIS and already installed Epic electronic medical record (EMR), reduction in the number of systems and interfaces, and positive patient identification (PPID). The build was significantly customized and included a first of its kind Epic-to-Epic interface. This was due to the clinical laboratory serving two hospitals (pediatric and adult) with independent instances of Epic.
Results: Test turnaround times showed improvement from historical baselines, mostly because of the implementation of PPID. PPID also resulted in significant reduction in mislabeled specimens.
Conclusions: Epic 2014
Beaker clinical pathology is a viable LIS with adequate functionality for a large academic center. Strengths include PPID and integration with the EMR. Integration provides laboratory users with ready access to the patient's relevant clinical history to assist releasing of results and gives physician and nurse providers sophisticated add-on ordering and specimen collection workflows. Areas that could use further development include specimen aliquoting, quality control reporting, and maintenance tools.
Epic has become the dominant vendor for the electronic medical record (EMR) for academic centers and large health care organizations in the United States. The Epic EMR includes cleverly named modules such as Ambulatory, OpTime, Willow, and Stork that assist, automate, and document activities related to patient care and its administration. In recent years, Epic has made significant development in the Beaker Clinical Pathology module, which is a laboratory information system (LIS) integrated with the Epic EMR. To date, adoption of Beaker has been relatively limited, particularly among large academic centers.
The Epic modules collectively represent an integrated health care information system with different functional yet interrelated modules that exchange information without the need for Health Level 7 (HL7) interfaces. Given the advantages of consolidation, including reduction of vendors and elimination of costly and complex interfaces, health care administrators and chief information officers have shown great interest in adopting Epic as an integrated solution. 1 In particular, Beaker is seen as a cost-effective replacement for the traditional, standalone LIS. Epic offers separate Beaker Clinical Pathology (CP) and Beaker Anatomic Pathology (AP) modules that can be implemented individually or together. Collectively, the Beaker modules offer integrated reporting of AP and CP tests. In 2012, Stanford University Medical Center, which had been live with the Epic EMR since 2008, selected Beaker CP to replace Sunquest. Implementation of Beaker AP was deferred to a later date. The rationale for selecting Beaker included the desire for integration between LIS and EMR, future integration between Beaker AP and CP, and positive patient identification (PPID). In this report, we
Institutional Description
Stanford University Medical Center comprises the Stanford School of Medicine, Stanford Health Care (SHC) with the 613-bed adult hospital and clinics, and Stanford Children's Health (SCH) with the 311-bed Lucile Packard Children's Hospital and clinics. SHC and SCH are independent business entities with separate administrative, financial, and information technology (IT) systems and support Figure 1A . SHC includes an American College of Surgeons level 1 trauma center and National Comprehensive Cancer Network cancer center. The Stanford Clinical and Anatomic Pathology laboratory is administered by SHC, is supported by SHC IT, and provides services to SHC, SCH, and outside clients. Locations include an onsite laboratory at SHC hospital for high-volume chemistry, hematology, coagulation, send-out, and transfusion-related testing; an offsite laboratory 3 miles from SHC at Hillview for all other testing; and three satellite laboratories associated with clinics. In 2012, the laboratory performed 5.3 million billable tests. The Stanford Department of Pathology resides within the Stanford School of Medicine and includes 53 clinical faculty and 53 residents and fellows. The department also includes the Stanford Blood Center, which receives blood donations and performs human leukocyte antigen (HLA) testing for transplant services.
Selection Process
A formal request for proposal was issued to vendors, and Cerner, SCC Soft Computer, and Epic were selected as final candidates. Sunquest was not a final candidate because of the lack of sufficient AP/CP integration. Cerner produces both LIS and EMR software, and its Millennium product offers integration between AP and CP modules, a molecular diagnostics module, and a blood bank module. Millennium can be used as a stand-alone LIS connected to an EMR through an HL7 interface or as an integrated system with Cerner's EMR. By contrast, Epic Beaker is not intended to function as a stand-alone LIS and must be installed with Epic's EMR. Beaker offers AP and CP modules but no molecular diagnostics or blood bank module. SCC Soft Computer produces a stand-alone LIS and does not offer an EMR product. The Soft LIS offers integration between AP and CP modules, a molecular diagnostics module, and a blood bank module.
Candidates gave onsite demonstrations that were scored, and reference calls were placed to selected clients. Five site visits to laboratories with live installations were conducted with a team of four pathologists, four laboratory managers and directors, three laboratory IT analysts, and two hospital IT leaders. Beaker was selected based on these activities and the fact that Stanford had been live on Epic's EMR since 2008.
Before and After Go-Live Systems
Pre-Beaker, information systems included Sunquest (version v6.3.99; Sunquest, Tucson, AZ) and PowerPath (version 10.0.1.10; Sunquest), both of which were interfaced to two separate instances of Epic version 2014 (Epic, Verona, WI), one at SHC and one at SCH Figure 1B . SafeTrace TX (version 3.9; Haemonetics, Braintree, MA) was interfaced to Sunquest. A unidirectional, real-time HL7 interface fed Sunquest and PowerPath data to a custom SQL-based Rhodes Group Clinical Results Repository (Vernon, CT) for management reports.
Beaker 2014 was installed on the SHC instance of Epic. A custom Epic-to-Epic interface was implemented to provide Beaker services to SCH Figure 1C .
SafeTrace TX was interfaced to SHC Epic/Beaker for orders and results of tests and to both instances of Epic directly for blood products to allow implementation of the Epic blood product administration module (BPAM); BPAM allows scanning of patient wrist band and blood product barcodes to improve transfusion accuracy. PowerPath retained its interfaces to SHC Epic and SCH Epic. An HL7 interface from Beaker fed real-time data to the Rhodes Repository.
Build
Implementation followed Epic's Good Install program and Flight Plan (see galaxy.epic.com). Based on information gathered from onsite visits and calls, Epic configured Beaker to accommodate Stanford workflows. No changes to the Beaker code were made. Although the Epic-to-Epic custom interface required significant development, custom coding was limited to the interface and did not involve either instance of Epic. Stanford analysts built content in Beaker/ Epic, including orders, results, test records, autoverification logic, quality control, call workflows, specimen storage, tracking, reporting, and billing. The Beaker facility structure is shown in Supplementary Figure 1 Tests performed on noninterfaced instruments or kits were built as Epic orderable procedures that are resulted directly in the EMR through the results console. For send-out testing, both interfaced and noninterfaced tests were built as test records in Beaker. For noninterfaced tests, external reports were scanned and uploaded to the Epic media tab and accessible from a hyperlink from the laboratory results tab. Transfusion services built all orderable tests such as type and screen in Beaker, which was interfaced to SafeTrace TX. Testing instruments were interfaced to SafeTrace TX. Blood product orders placed in either instance of Epic were directly transmitted to SafeTrace TX. HLA testing at Stanford was performed at the Stanford blood bank, which is external to SHC and treated as an interfaced send-out laboratory. Cytogenetic reporting remained entirely in PowerPath. For instrument and manual testing quality control (QC), Beaker was used throughout all technical sections. For QC reporting, a combination of Beaker QC reports and customized reports using the Rhodes repository was used.
Foundation system Epic/Beaker add-on order functionality was used for SHC, but customization was necessary for SCH. For SHC, when a provider in Epic order entry selects a test that is eligible as an add-on, he or she can chose to perform it on an already collected specimen or request a new collection. Eligibility is based on the existing specimen's time since collection and other configurable rules. Also, the existing specimen must be in a container type that is compatible with the add-on test. Add-on orders are received in Beaker as a message in a specific in-basket for the performing technical section. A technologist assesses the specimen, and if there is sufficient residual volume, the test is added to the specimen; otherwise, the technologist can request a new collection from Beaker without requiring the provider to reorder the test.
These flexible add-on workflows are not available at SCH because the functionality is part of the integrated Epic/ Beaker system. As a workaround, SCH providers can request an add-on by submitting an order and selecting an option listed as "add-on." These orders are received in Beaker as an in-basket message. If there is an eligible specimen with sufficient residual volume, the test is added to the specimen. However, the Beaker logic that determines whether an eligible specimen exists in the laboratory is not accessible through the interface, so it is possible to order an add-on without an existing eligible specimen. In addition, the technologist cannot request a new collection from Beaker. To initiate a new collection, the test is cancelled, and the laboratory must call the provider to reorder the test. Given these differences, SCH add-ons are routed to an entirely separate in-basket.
Critical calls also use standard Beaker functionality, but additional steps are necessary because of the interface. Critical calls are placed and completed using the communication log, which posts call documentation to SHC Epic at the test level. Communication log data were not included in the interface, which necessitated call documentation as component-level comments to post to SCH Epic. Comments were added as a result correction to a final verified result component, and these comments posted to both SHC and SCH Epic. Component-level comments have the benefit of identifying which components of a multicomponent test were communicated as critical values. The workflow requires documentation in both the communication log and result comment because the critical call TAT is derived from a time stamp that is available from the communication log but not from component-level comments. Critical values are assigned a follow-up task that is monitored in a follow-up work list. The customer service department handles critical calls 24/7 except for downtimes and breaks during off hours.
PPID
Collection with PPID was implemented in the inpatient and emergency department but not in the operating room or ambulatory settings. Both inpatient nurses and laboratory phlebotomists collected specimens using PPID. Although full PPID with patient wristband scanning was not performed in ambulatory settings, label printers were placed at the collection sites to ensure printing of labels at the time and place of collection, and specimens were scanned following collection. Nurses accessed Epic using HewlettPackard (Palo Alto, CA) computer workstations on wheels with Gryphon GD4400-B (Datalogic, Eugene, OR) barcode scanners and Intermec PB50 (Honeywell, Fort Mill, SC) wireless mobile label printers. Laboratory phlebotomists accessed Epic Rover using Apple (Cupertino, CA) iPoD touch (fifth generation) mobile devices with Captuvo SL22h enterprise sleds (Honeywell) synced to Intermec (Everett, WA) PB50 printers. The total numbers and specific models of PPID equipment are listed in Supplementary Table 2 .
The PPID workflow was initiated by scanning the patient's barcoded wristband to print labels at the bedside. Labels were affixed to tubes, specimens were collected, and each specimen was scanned to automatically populate the collection information. Because of limitations in the Epicto-Epic interface, functionality differs between SHC and SCH. Beaker 2014 requires only one container in a multicontainer specimen to be scanned. Thus, for SHC, scanning any container of a multicontainer specimen completes the collection process, but for SCH, scanning must be done on the first container to avoid an error. This was because the Beaker multicontainer logic was not transmitted through the interface.
Also, at SHC, specimen collection can be switched from nurse to phlebotomist or vice versa, whereas at SCH, the switch can only occur unidirectionally from nurse to phlebotomist. Again, the Beaker logic that supports this functionality was not included in the interface. Thus, urgent specimen collections cannot be switched from phlebotomist to nurse without requiring a new order.
Timeline and Personnel
The high-level timeline is shown in Figure 2 . An organizational chart of individuals involved in implementation is shown in Supplementary Figure 2 . The laboratory also engaged 28 subject matter experts (SMEs) from the technical and administrative areas, eight of whom were certified as credentialed trainers.
Testing
The testing plan included eight major tracks: workflow/ application (including other Epic modules), interface, reporting, DI/instrument, laboratory, parallel revenue cycle, hardware, and end user. Laboratory testing was performed by SMEs to test all 1,766 tests, including all rules (automated comments, reflex actions, etc). For reference ranges, a report was generated that extracted all test reference ranges. The report content was checked for accuracy by manually comparing to build specifications. For one of 50 tests, SMEs functionally tested reference ranges using test patients to trigger all age-and sex-specific ranges. During testing, the reference range report always reflected the actual functionality. Autoverification testing involved end-to-end testing using actual patient samples to fire hundreds of different automated comments and/or fulfilling the criteria for autoverification.
Training
The training plan, training materials, and go-live educational content were prepared by the Epic-certified principal trainer (PT). The PT coordinated activities, scheduled courses, and managed hardware and Beaker environment needs for training sessions. Four months before go live, eight laboratory employees were trained as Epic credentialed trainers (CT) by the PT in a 6-week program. Two months before go live, 49 superusers (SUs) were trained by the CTs in a 2-week program. Most CTs and SUs were SMEs, and their training also included skills for go-live support. One month before go live, more than 600 Beaker end users (EUs) were trained by the CTs. Content for EU training is summarized in Supplementary Table 3 . For PPID training, analysts held in-person training sessions on the floors and trained PPID super users during the 2 weeks prior to go live. Ordering providers were trained through online resources, flyers, and face-to-face drop-in workshops.
Go-Live Plan
A main command center in the Stanford Hospital laboratory and command centers at the offsite Hillview laboratory and IT headquarters were established on February 20, 2015, at 3:00 PM. On February 21, 2015, at 1:00 AM, the Epic order queue was stopped, but Epic clinical functionality, including notes, flowsheets, and inbound laboratory results, were retained. Between 1:00 AM and 3:35 AM, the laboratory accepted orders on paper that were manually entered into Sunquest. Beaker went live at 3:35 AM. From February 21 to 24, 2015, all three command centers were staffed 24/7 for support; from February 25 to March 2, 2015, hours were reduced to 7 AM to 7 PM for the main command center and 8 AM to 5 PM for the others. For 3 days after go live (through February 24, 2015), application analysts rounded the laboratory and clinics, and the laboratory staffed Beaker SMEs for high availability to provide end-user support. Following go live, the consultants on the build team were maintained at Stanford for 3 months to assist with support and build issues. As of 2016, a total of eight analysts support the Beaker application.
Data Analysis
Test TATs were calculated within the Rhodes database based on the time interval from receipt in the laboratory to first preliminary or final verification. For received-to-bench and bench-to-verify intervals, bench time was derived from the tracking event created when the specimen was delivered to the specific technical section. For specimens with multiple tests performed in different sections, the test bench time was determined by using the first eligible tracking event associated with the test. Eligible tracking locations for each test were maintained in a table in the Rhodes database. The 90th percentile was defined as the time in which 90% of the tests or intervals were competed. Critical call TAT was defined as the time between final verification and call completion. The number of mislabeled specimens per month was determined by searching the SHC event reporting system for incidents classified as mislabeled specimens. To specifically evaluate the effect of full PPID, only incidents in the inpatient setting with the exclusion of the operating room were counted. Incidents counted as a mislabeled specimen included when the specimen label did not match the patient, Figure 2 Timeline for implementation. AV testing did not occur during the planned testing timeline because iterative testing was completed late. As a result, go live was postponed from February 7, 2015, to February 21, 2015. AV, autoverification; PPID, positive patient identification; SME, subject matter expert.
when two labels were placed on a single specimen, or when a label did not match an associated paper requisition. Errors unaffected by PPID such as improper label placement and printing errors were excluded. Comparable data from SCH were not available.
A standard Epic end-user survey was given to users 60 days after go live. The survey asked users in the laboratory the following questions, with higher number answers indicating greater satisfaction: (1) "How would you rate the support you received?" (1 to 5); (2) "Rate this statement: navigating the system is easy and intuitive" (1 to 4); (3) "I was prepared for Epic by the training I received" (1 to 4); (4) "Rate this statement: Epic makes me more efficient in my day-to-day job than I was before" (1 to 5); (5) "How would you rate the quality of patient care now compared with before Epic?" (1 to 5); and (6) "Overall, how satisfied are you with Epic?" (1 to 10). From 80 total responses, mean scores per question were calculated and compared with mean scores from other Beaker implementations (provided by Epic), and the relative difference from the mean was expressed as a percentage.
Results/Discussion
Implementation generally followed the timeline shown in Figure 2 , although the time required for iterative testing was greatly underestimated. This phase of testing consisted of 3,897 scripts performed by SMEs to test the ordering, resulting, rules, reporting, and critical value flagging of all 1,766 tests. Iterative testing began on September 5, 2014, and was completed 1 month late on November 26, 2014. The delay was partly due to the SMEs' learning curve for Beaker and Epic order entry. Also, nearly 20% of scripts initially failed because of errors in build or change requests. Because build analysts were located offsite, the process of communicating issues, rebuilding, and retesting was inefficient. In retrospect, if iterative testing had been carried out side-by-side with SME and build analysts, the process would have been more efficient. During implementation, iterative testing was the largest time commitment for SMEs, and their absence from daily operations placed significant burden on the laboratory.
The additional time required for iterative testing delayed the start of autoverification validation, which requires testing with actual patient samples as recommended by Clinical and Laboratory Standards Institute guidelines. 2 Most sections had limited autoverification rules and completed validation in time for go live. However, chemistry had over 100 tests with more than 1,000 automated rules to validate. Similar to iterative testing, the offsite location of build analysts affected the process, and validation could not be accelerated to meet the originally planned go-live date of February 7, 2015 . Given the high volume of testing and operational reliance on autoverification since 2008, the risk of going live with manual processes was deemed unacceptable by the medical directors.
The medical directors, administrative leadership, and IT agreed to delay go live by 2 weeks until February 21, 2015. To meet the new date, the list of chemistry tests necessary to be validated for autoverification was limited to high-volume tests and those considered high risk for error with manual review. Electrolytes and enzymes were required, but therapeutic drugs, immunosuppressive drugs, and urine chemistries were desired but not considered essential. The build analysts and IT support were moved onsite within the laboratory to increase the efficiency of testing. This arrangement resulted in greater collaboration between IT and operations and, in retrospect, should have occurred earlier in the project.
The delay in go live allowed the laboratory to address gaps in education, which was general and not section specific. For example, our Beaker courses included result verification of basic test values, but keyboard entry of a manual differential for CBCs and identification of an organism from a microbiologic isolate were not included. The SMEs from hematology and microbiology organized supplemental training sessions to address section-specific functionality. These ad hoc training sessions were well received, but ideally the material would have been included in the formal courses and materials. For add-on tests and critical calls, limitations in the Epic-to-Epic interface necessitated complex, nonstandard workflows and menus. Although these topics were covered in Beaker courses, our technologists requested additional training sessions.
Following the 2-week delay, Beaker go live successfully occurred on Saturday, February 21, 2015, at 3:35 AM. In terms of support, the peak of new IT tickets occurred on February 22, with the volume gradually falling over the first week (Supplementary Figure 3) . In the first 48 hours, the most common issues were related to hardware and wireless connectivity, which affected label printing and PPID. Our onsite laboratory SMEs also reported frequent issues with Beaker login that were addressed in person without requiring a formal IT ticket.
Over the first week, the most common IT support tickets were related to build. In this regard, the extensive 24/7 support planned through the command center and onsite IT analysts was well used. For example, during the go-live preparation, we discovered that for tests with sex-specific reference ranges and critical values, the flagging rules would not apply when the patient sex was entered as unspecified. This situation occurs with occasional trauma or newborn patients and introduces a risk of missing a critical call and reporting results without a critical value flag. With sufficient support resources, we were able to add reference ranges and critical values for unspecified sex for affected tests within the first 12 hours of go live.
It should be noted that issues with hardware and build were common despite extensive testing of 100% of devices and tests. Nevertheless, the volume of issues was not surprising, given the scope of build and number of devices (Supplementary Table 2 Figure 3A is the monthly TAT for inpatient comprehensive metabolic panel testing (METC). Prior to Beaker, the 90th percentile TAT for METC ranged from 60 to 80 minutes, with 20 to 30 minutes for the receive-to-bench (preanalytic) time and 40 to 60 minutes for the bench-to-verify (analytic) time. For the go-live month of February 2015, the TAT jumped to 91 minutes, with a 26-minute preanalytic time and 76-minute analytic time. However, by April, the TAT had improved to 56 minutes, with a 9-minute preanalytic time and 52-minute analytic time.
The improvement in analytic time was gradual and associated with the phased addition of additional autoverification logic. Autoverification for urine chemistry, therapeutic and immunosuppressive drugs, and blood gases went live in February, March, and April 2015, respectively. By contrast, the improvement in preanalytic time was immediate and the result of more automated accessioning processes because of PPID. With Beaker and PPID, the collection information is recorded and transmitted electronically, whereas previously, the collection time, date, and collector were handwritten on the specimen label and entered upon accessioning. PreBeaker, the laboratory also received a large number of paper requisitions, but with the switch to PPID, the laboratory no longer accepted handwritten orders. Thus, providers were forced to use electronic order entry, which by itself can have a positive effect on TAT. 4, 5 In addition, nurses were trained in PPID shortly before go live, resulting in a high percentage of specimens that were properly collected and labeled. With Beaker, most specimens required only barcode scanning upon receipt, whereas pre-Beaker, accessioning required significant manual data entry.
For hematology, go live was associated with an immediate improvement in inpatient CBC TAT Figure 3B . In contrast to chemistry, all analytes previously autoverified in Sunquest, which consisted of the CBC and basic coagulation, were validated for go live. Pre-Beaker, the TAT ranged from 40 to 60 minutes, with a 20-to 30-minute preanalytic time and 20-to 40-minute analytic time. With Beaker, the TAT improved to around 20 minutes, with an approximately 5-minute preanalytic time and 15-minute analytic time. The TAT for prothrombin time also showed improvement, although this was entirely due to the preanalytic time, and the analytic time was similar to the historic baseline Figure 3C . Overall, the improvement in chemistry and hematology brought our inpatient testing TAT close to the median for emergency department testing as reported by a College of American Pathologists Q-Probe of 952 hospital laboratories. 6 Critical value notification TAT and mislabeled specimens are additional laboratory KPIs. Beaker go live was initially associated with fewer critical calls meeting the 15-minute target (Supplementary Figure 4) . The historical compliance rate was 96% to 97% of calls completed in less than 15 minutes, but from February 2015 through April 2015, this figure dropped to 92% to 94%. The compliance returned to 96% by July 2015 and has remained at 96% to 97%. The median time from final verified result to provider notification was 3.0 minutes pre-Beaker, 4. The implementation of PPID resulted in a significant reduction in the number of mislabeled specimens for inpatient collections at SHC Figure 4 . Full PPID with patient wristband scanning was not implemented for outpatient collections, and data were not available from SCH. Pre-Beaker, the laboratory received three to seven mislabeled specimens per month, but following go live, none were reported from March 2015 through July 2015. However, by August 2015, mislabeled specimens recurred, albeit at a lower rate than before go live. We surmise that implementation of PPID and the associated training in specimen collection both contributed to reducing mislabeled specimens, but over time, the enthusiasm for PPID and benefits of training waned. The recurrence of mislabeled specimens may also reflect increasing nursing workload or turnover. Overall, our results are similar to those of Morrison et al, 8 who reported that barcode-based PPID resulted in a twofold reduction in mislabeled specimens, but inferior to those of Hayden et al, 9 who observed a sevenfold reduction in errors.
In terms of the implementation process, aspects we considered successful include the go-live support, testing, and For example, our understanding that critical call documentation in the communication log would not pass through the Epic-to-Epic interface was not realized until testing. Settings in the laboratory system definitions master file, including parameters for add-ons, auto-cancellation, and charges/holds, were discussed frequently as they have operational ramifications that must be considered on a test, section, and facility level. We consider reporting and metrics a high priority, and we devoted four full-time equivalents (FTEs) to have nearly all of the 422 reports completed by go live. We used the Epic reporting workbench for most reports (213 of 422), given that it is readily accessible from Epic/Beaker. Because the reporting workbench accesses the live Caché database, reports are best suited to a short date range (<2 weeks); otherwise, the request may require minutes to hours. For complex reports and better performance, Epic offers out-of-the-box Crystal reports that access the Clarity database, which is an SQL translation of the Caché database. However, reports are based on the Beaker foundation system, and deviations in build may require modification of the report. Our other reports consisted of four Crystal reports and 207 Rhodes repository reports. We elected to use Rhodes because our laboratory had familiarity with using these reports for Sunquest data, and the continuity would allow comparison of pre-Beaker vs Beaker TATs. We also use Rhodes to store, retrieve, and produce reports for archival Sunquest data.
We encountered considerable technical challenges implementing the custom Epic-to-Epic interface that required significant workarounds and limitations in functionality for the interfaced instance of Epic at SCH. It should be noted that this is the first implementation of an Epic-to-Epic interface, but following go live and stabilization, Epic has continued to make enhancements. SCH add-ons can now be sent for a new collection without requiring a new order, and SCH specimen collections can be toggled from phlebotomist to nurse. Nevertheless, the Epic-to-Epic interface introduces a complexity that requires additional build, maintenance, and support that counter the benefits of an integrated LIS.
As a relatively recently developed LIS, Beaker 2014 has areas that could benefit from further improvement, including QC, aliquoting, the procedure catalog (test menu), and maintenance tools. In general, QC reporting is adequate, but tools for analysis and review are lacking. For example, evaluation of numerical QC on a monthly Levy-Jennings graph is readily accomplished, but comparison to prior months requires the user to rerun the report from the prior month or manually recall it based on the report number. Similarly, supervisors can electronically sign QC reports, but a second reviewer, such as a medical director, must manually recall the report by number for electronic signature. Finally, there is no blind duplicate QC testing functionality. These limitations were identified during project planning, and building QC using DI middleware was considered. Ultimately, we chose Beaker QC to minimize complexity, but we anticipate future development in this area. Figure 4 Mislabeled specimens. The number of specimens in which the patient name on the label affixed to the specimen was incorrect. Data are for inpatient draws in the Stanford Health Care adult hospital.
Specimens can be aliquoted into multiple containers that have a .1, .2, or .x suffix added to the specimen ID. Unfortunately, aliquots must be manually ordered rather than created automatically based on rules. When aliquots are created, all tests for the specimen are downloaded onto all aliquots. This issue required significant operational workarounds, including unnecessarily running all aliquots on all instruments. Similarly, all aliquots must be tracked to the same location, and operational steps were necessary to ensure that aliquots were all delivered to their final destination. Fortunately, aliquoting has been significantly enhanced in Beaker 2015.
The Beaker procedure catalog is automatically populated by the test build content and can be accessed from both Beaker and Epic, including the order entry screen. For Beaker 2014, the procedure catalog is only accessible within the Epic/Beaker environment, and there is no web-based portal for external clients. To serve our external clients and SCH, we manually load content about our tests to an external website (www.stanfordlab.com). With our website, we are able to offer additional content that is not readily accommodated by the procedure catalog, including clinical specialty, method, Z codes, and other customized content. Given this functionality, even our SHC providers frequently use the test directory at www.stanfordlab.com.
Another Beaker omission is the lack of tools to address orders that have not been fully acted upon. For example, the specimen collection activity generates an accession number, but occasionally, the collection is not completed due to issues with the draw. This results in an accession number that is never received in the laboratory but remains on the expected list. Most mature LISs have tools to address these specimens and associated orders, but with Beaker, the process is manual and requires significant analyst time. It should be noted that Beaker can automatically cancel specimens that have not been received based on rules, but this approach must be used judiciously.
Another challenge with Beaker was the absence of a predefined bench "spot" for technical sections. This concept allows precise tracking within the laboratory and determination of the receive-to-bench and bench-to-verify intervals of the TAT. These time intervals are not available in the Epic reporting workbench. To address this, we created a bench tracking location for each technical section, and our workflow includes scanning a specimen upon receipt to the section, which creates a time stamp for bench receipt associated with the specimen ID. Because a specimen can have multiple tests that are performed in different sections, determining the bench time for a test requires complex logic. The coding is done in the SQLbased Rhodes Repository, and the front end for accessing TAT reports is through SQL Server Reporting Services (Microsoft, Redmond, WA) or Web Intelligence (SAP, Walldorf, Germany) that is accessed from a hyperlink on the Beaker dashboard. It should be noted that our preanalytic time improved dramatically with Beaker and PPID, and there is less necessity to monitor this time interval.
End-user feedback and satisfaction were moderately positive, as evaluated through a standardized Epic survey given 60 days after go live. The scores and their relative difference to mean scores from Beaker implementations at other sites were as follows: support (3.4 out of 5; þ3.2%), ease of use (2.7 out of 4; þ14.3%), training (2.5 out of 4; þ10.2%), system efficiency (3.0 out of 4; þ15.4%), patient care (3.2 out of 4; þ15.0%), and satisfaction (5.5 out of 10; þ10.0%). A common end-user comment was that training was insufficient and not section specific. Many of these comments originated from microbiology, which had complex workflows that differed greatly from Sunquest.
Overall, given the measurable results of implementation, we have been highly satisfied with Beaker as an LIS. Krasowski et al 3 describe similar results with Beaker implementation, including baseline to improved testing TATs and positive end-user satisfaction. We encountered shortcomings in aliquoting, QC, and maintenance tools, but based on the rate of Beaker development, we expect these issues to be addressed in the near future. The strengths of the current system include PPID and integration with the Epic EMR, which allows for sophisticated add-on functionality and specimen collection workflows. The advantages of integration also include reduction of cost and complexity, but the benefit to patient care cannot be overstated. For example, patient diagnoses/International Classification of Diseases, 10th Revision codes are listed on screens where the CBC and peripheral blood smear review are performed. In addition, the ease of access to the patient's history, medications, and current problems provides clinical context for interpreting and resulting tests. Thus, we view Epic/Beaker as a patient-centric integrated system, and we anticipate increasing adoption by academic centers and large health care organizations along with continued development in the product.
